Background: Ensuring vaccine acceptance in societies is a growing challenge for healthcare systems worldwide. This study aimed to identify factors associated with vaccine acceptance rates. Methods: This cross-sectional study was conducted as a national web-based survey from February 9th-13th, 2021, just before the release of the COVID-19 vaccine in Shiraz, Iran. Independent variables included age, gender, occupation, history of COVID-19 infection, underlying diseases, and source of information. The willingness to be vaccinated was the dependent variable. A logistic regression analysis was performed to determine the relationship between different variables and the willingness to receive the COVID-19 vaccine. The significance level was set at less than 0.05. The data were analyzed using SPSS software version 21. Results: Of 2,699 healthcare respondents, 70.3% indicated a willingness to receive the COVID-19 vaccine, of whom 49.2% preferred to receive a foreign vaccine and 24.68% desired to receive an Iranian vaccine. The women were more willing to receive the vaccine (67.6%) than the men (78.2%). Based on the results of logistic regression, gender (P<0.001) and job (P=0.005) were the most important associating factors to the willingness to receive the COVID-19 vaccine. Conclusion: Although the majority of participants were willing to receive the COVID-19 vaccine, 29.6% were not yet ready. Women’s healthcare providers were more hesitant to recommend the vaccine. As a result, the findings of this study can help policymakers and decision-makers in the field of health, treatment, and prevention of COVID-19 in raising the level of vaccination awareness among healthcare workers. |
- Organization WH. Behavioural considerations for acceptance and uptake of COVID-19 vaccines: WHO technical advisory group on behavioural insights and sciences for health, meeting report, 15 October 2020. Geneva: World Health Organization; 2020.
- Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, et al. The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int J Surg. 2020;78:185-93. doi: 10.1016/j.ijsu.2020.04.018. PubMed PMID: 32305533; PubMed Central PMCID: PMCPMC7162753.
- Laine C, Cotton D, Moyer DV. COVID-19 Vaccine: Promoting Vaccine Acceptance. Ann Intern Med. 2021;174:252-3. doi: 10.7326/M20-8008. PubMed PMID: 33347321; PubMed Central PMCID: PMCPMC7901662.
- Habersaat KB, Jackson C. Understanding vaccine acceptance and demand-and ways to increase them. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020;63:32-9. doi: 10.1007/s00103-019-03063-0. PubMed PMID: 31802154; PubMed Central PMCID: PMCPMC6925076.
- Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020;35:775-9. doi: 10.1007/s10654-020-00671-y. PubMed PMID: 32785815; PubMed Central PMCID: PMCPMC8851308.
- Dubé E, MacDonald NE. Vaccine acceptance: barriers, perceived risks, benefits, and irrational beliefs. The Vaccine Book: Elsevier; 2016. p. 507-28. doi: 10.1016/B978-0-12-802174-3.00026-6.
- Molavi H, Sharifi H, Delavari S, Sharifi MH. Public Adults Information Seeking Behaviors During Early Weeks of COVID-19 Epidemic: Early Lessons for Improvement of Epidemic Communication. Shiraz E Medical Journal. 2020;21. doi: 10.5812/semj.107487.
- Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, et al. Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia. Front Public Health. 2020;8:381. doi: 10.3389/fpubh.2020.00381. PubMed PMID: 32760691; PubMed Central PMCID: PMCPMC7372105.
- Al-Mohaithef M, Padhi BK. Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey. J Multidiscip Healthc. 2020;13:1657-63. doi: 10.2147/JMDH.S276771. PubMed PMID: 33262600; PubMed Central PMCID: PMCPMC7686470.
- Nguyen T, Henningsen KH, Brehaut JC, Hoe E, Wilson K. Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public. Infect Drug Resist. 2011;4:197-207. doi: 10.2147/IDR.S23174. PubMed PMID: 22114512; PubMed Central PMCID: PMCPMC3215344.
- Horney JA, Moore Z, Davis M, MacDonald PD. Intent to receive pandemic influenza A (H1N1) vaccine, compliance with social distancing and sources of information in NC, 2009. PLoS One. 2010;5:e11226. doi: 10.1371/journal.pone.0011226. PubMed PMID: 20585462; PubMed Central PMCID: PMCPMC2887902.
- Rubin GJ, Potts HW, Michie S. The impact of communications about swine flu (influenza A H1N1v) on public responses to the outbreak: results from 36 national telephone surveys in the UK. Health Technol Assess. 2010;14:183-266. doi: 10.3310/hta14340-03. PubMed PMID: 20630124.
- Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020;26:100495. doi: 10.1016/j.eclinm.2020.100495. PubMed PMID: 32838242; PubMed Central PMCID: PMCPMC7423333.
- Fadda M, Albanese E, Suggs LS. When a COVID-19 vaccine is ready, will we all be ready for it? Int J Public Health. 2020;65:711-2. doi: 10.1007/s00038-020-01404-4. PubMed PMID: 32529534; PubMed Central PMCID: PMCPMC7288619.
- Gadoth A, Halbrook M, Martin-Blais R, Gray A, Tobin NH, Ferbas KG, et al. Cross-sectional Assessment of COVID-19 Vaccine Acceptance Among Health Care Workers in Los Angeles. Ann Intern Med. 2021;174:882-5. doi: 10.7326/M20-7580. PubMed PMID: 33556267; PubMed Central PMCID: PMCPMC7926184.
- Honarvar B, Odoomi N, Mahmoodi M, Kashkoli GS, Khavandegaran F, Bagheri Lankarani K, et al. Acceptance and rejection of influenza vaccination by pregnant women in southern Iran: physicians’ role and barriers. Hum Vaccin Immunother. 2012;8:1860-6. doi: 10.4161/hv.22008. PubMed PMID: 23032162; PubMed Central PMCID: PMCPMC3656077.
- Murphy J, Vallieres F, Bentall RP, Shevlin M, McBride O, Hartman TK, et al. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat Commun. 2021;12:29. doi: 10.1038/s41467-020-20226-9. PubMed PMID: 33397962; PubMed Central PMCID: PMCPMC7782692.
- Kuppalli K, Brett-Major DM, Smith TC. COVID-19 Vaccine Acceptance: We Need to Start Now. Open Forum Infect Dis. 2021;8:ofaa658. doi: 10.1093/ofid/ofaa658. PubMed PMID: 33623802; PubMed Central PMCID: PMCPMC7798542.
- Kreps S, Prasad S, Brownstein JS, Hswen Y, Garibaldi BT, Zhang B, et al. Factors Associated With US Adults’ Likelihood of Accepting COVID-19 Vaccination. JAMA Netw Open. 2020;3:e2025594. doi: 10.1001/jamanetworkopen.2020.25594. PubMed PMID: 33079199; PubMed Central PMCID: PMCPMC7576409.
- Puri N, Coomes EA, Haghbayan H, Gunaratne K. Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases. Hum Vaccin Immunother. 2020;16:2586-93. doi: 10.1080/21645515.2020.1780846. PubMed PMID: 32693678; PubMed Central PMCID: PMCPMC7733887.
- Wilson SL, Wiysonge C. Social media and vaccine hesitancy. BMJ Glob Health. 2020;5. doi: 10.1136/bmjgh-2020-004206. PubMed PMID: 33097547; PubMed Central PMCID: PMCPMC7590343.
- Sharma O, Sultan AA, Ding H, Triggle CR. A Review of the Progress and Challenges of Developing a Vaccine for COVID-19. Front Immunol. 2020;11:585354. doi: 10.3389/fimmu.2020.585354. PubMed PMID: 33163000; PubMed Central PMCID: PMCPMC7591699.
- Moghaddami M, Amini M. Barriers to Influenza Immunization. Shiraz E-Medical Journal. 2017;18. doi: 10.5812/semj.55914.
- Abolghasemi J, Farboodniay Jahromi MA, Hossein Sharifi M, Mazloom Z, Hosseini L, Zamani N, et al. Effects of Zataria oxymel on obesity, insulin resistance and lipid profile: A randomized, controlled, triple-blind trial. J Integr Med. 2020;18:401-8. doi: 10.1016/j.joim.2020.06.003. PubMed PMID: 32651141.
|